FOYA TAVANGARY: Open Payments
NPI 1831826106 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,237 in 55 payments from 17 companies in 2025. Trend: 2023 $1,872 · 2024 $1,626 · 2025 $1,237
Food & beverage: $1,218Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $299 |
| Novo Nordisk Inc | 16 | $189 |
| Exact Sciences Corporation | 3 | $129 |
| ViiV Healthcare Company | 3 | $100 |
| Braeburn Inc. | 3 | $82 |
| Indivior Inc. | 2 | $59 |
| Gilead Sciences, Inc. | 2 | $57 |
| Sage Therapeutics, LLC | 2 | $56 |
| Amgen Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
Products named: Wegovy, The Cologuard Plus Collection Kit, MAVYRET, APRETUDE, VRAYLAR, BRIXADI, SUBLOCADE, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
